Search results
Author(s):
Ernest Spitzer
,
Ben Ren
,
Felix Zijlstra
,
et al
Added:
3 years ago
Left ventricular ejection fraction (LVEF) is the most widely used parameter of left ventricular (LV) systolic function, and its deterioration is associated with reduced survival rates.1 LVEF is expressed as a percent value, and calculated by dividing the stroke volume (enddiastolic volume minus end-systolic volume) by the end-diastolic volume and multiplying by 100; however, volume measurements…
View more
Author(s):
Douglas Bradley
Added:
1 year ago
ESC 22 - In this short interview filmed onsite at ESC Congress 2022, Dr Douglas Bradley (University of Toronto, Toronto, CA) discusses the findings of the ADVENT-HF Trial (NCT01128816).
ADVENT-HF was designed to determine if a respiratory device, Adaptive Servo Ventilation can reduce the risk of cardiovascular hospitalisations and death in patients with heart failure and sleep apnoea. 732…
View more
Jonathan Menachem
Research Area(s) / Expertise:
Job title: Director of Advanced Cardiac Therapies for Congenital Heart Diseases
Author
Christie Ballantyne
Job title: Chief of Cardiovascular Research and Director of the Center for Cardiometabolic Disease Prevention
Author
Author(s):
Martin R Cowie
,
Holger Woehrle
,
Olaf Oldenburg
,
et al
Added:
3 years ago
Heart Failure
In developed countries, approximately 1–2 % of the adult population has heart failure (HF), and the prevalence of this cardiovascular disease increases with age.1,2 HF can occur in the presence or absence of reduced left ventricular ejection fraction (LVEF), known as HF with reduced ejection fraction (HF-rEF) and HF with preserved ejection fraction (HF-pEF), respectively. The most…
View more
e-SPACE HF 2023 – Day Two
Author(s):
William T Abraham
,
Stefan Anker
,
Deepak L Bhatt
,
et al
Start date:
Oct 21, 2023
Broadcast
Author(s):
Ali Vazir
,
Kostantinos Bronis
,
Simon G Pearse
Added:
3 years ago
Central sleep apnoea (CSA) is characterised by cycles of apnoea, hypopnoea and hyperpnoea during sleep due to abnormalities in the regulation of breathing within the respiratory centre in the brainstem. CSA, defined as an apnoea–hypopnoea index (AHI) of ≥15 events/h, is common in patients with heart failure (HF), with a prevalence of 20–45 %.1, 2 Its presence is reported to be a marker of…
View more
Author(s):
William T Abraham
,
Adam Pleister
,
Robin Germany
Added:
3 years ago
Central sleep apnoea (CSA) occurs in approximately one-third of patients with HF and is associated with a significant increase in morbidity and mortality compared to HF patients without CSA.1–3 CSA results in intermittent hypoxia and activation of the renin–angiotensin system, which contributes to worsening HF.4 Symptoms such as fatigue and difficulty concentrating often overlap with the effects…
View more
Giuseppe Mancia
Job title: Chairman of the Department of Clinical Medicine and Prevention
Author
William T Abraham
Research Area(s) / Expertise:
Job title: Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine
Author